Language selection


2.0 About the audit

2.1 Audit objectives and scope

Audit objectives:

While VAC waits for research to catch up, this audit assessed what the Department is doing right now to address serious risks with this treatment benefit.

  • Given the experimental nature of CMP as a treatment, has VAC implemented controls to mitigate the risk to Veterans’ health and well-being?
  • Given the exponential growth of demand for the CMP treatment benefit, has VAC established controls to manage the financial impact on public funds?


The scope of the audit is VAC’s management of the treatment benefit CMP from 1 April 2019, to 31 December 2020. The audit excludes:

  • Health Canada’s licensing and inspection of Federal Licensed Sellers and
  • Medavie Blue Cross’s process for setting up / registering providers and Authorizers

The audit team conducted their work and analysis within the appropriate authorities of the department and following the Privacy Act. The audit findings and conclusions contained in this report are based on sufficient and appropriate audit evidence gathered in accordance with procedures that meet the Institute of Internal Auditors’ International Standards for the Professional Practice of Internal Auditing as supported by the results of the quality assurance and improvement program.

The opinions expressed in this report are based on conditions as they existed at the time of the audit and apply only to the entity examined.

Additional information including the audit criteria and methodology are provided in Appendices A and B.

Date modified: